GC Medical Science Corporation (KOSDAQ:142280)
South Korea · Delayed Price · Currency is KRW 3,105.00
+5.00 (0.16%)
At close: Sep 11, 2026
GC Medical Science Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 102,158 | 108,413 | 103,852 | 94,011 | 113,109 | 101,675 |
Revenue Growth | -8.46% | 4.39% | 10.47% | -16.89% | 11.25% | -10.32% |
Gross Profit Gross Profit Growth | 13,529 | 15,022 | 14,767 | 13,955 | 12,746 | 1,631 |
Operating Income Operating Income Growth | 2,368 | 2,887 | 2,261 | 1,272 | -1,808 | -20,164 |
Net Income Net Income Growth | -2,162 | 3,666 | 3,581 | 1,797 | -3,581 | -21,202 |
Earnings Per Share EPS Growth | -98.47 | 145.75 | 41.04 | 75.80 | -170.00 | -1006.40 |
EPS Growth | - | 255.16% | -45.86% | - | - | - |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Green Cross MS Co., Ltd. Green Cross MS Co., Ltd. Growth | 109,122 | 104,600 | 94,066 | 110,820 | 100,829 |
Green Cross Medis Co., Ltd. Green Cross Medis Co., Ltd. Growth | 15,833 | 13,163 | 11,756 | 14,884 | 12,789 |
Consolidated Adjustments Consolidated Adjustments Growth | -16,541 | -13,911 | -11,811 | -12,595 | -11,944 |
Total Total Growth | 108,413 | 103,852 | 94,011 | 113,109 | 101,675 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 261.34 | 372.63 | 678.49 | 5,744 | 10,751 | 1,843 |
Total Debt Total Debt Growth | 15,224 | 17,454 | 17,353 | 22,580 | 23,401 | 36,981 |
Net Cash (Debt) Net Cash Growth | -14,963 | -17,081 | -16,675 | -16,836 | -12,650 | -35,139 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -681.47 | -640.31 | -623.49 | -629.11 | -600.13 | -1667.93 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 8,357 | 7,196 | 3,661 | 4,241 | 10,880 | -18,195 |
Capital Expenditures CapEx Growth | -1,023 | -4,720 | -3,216 | -5,632 | -3,426 | -3,598 |
Free Cash Flow Free Cash Flow Growth | 7,334 | 2,476 | 445.24 | -1,391 | 7,454 | -21,793 |
Free Cash Flow Growth | - | 456.00% | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 13.24% | 13.86% | 14.22% | 14.84% | 11.27% | 1.60% |
Operating Margin | 2.32% | 2.66% | 2.18% | 1.35% | -1.60% | -19.83% |
Pretax Margin | -2.96% | 1.90% | 3.27% | 1.98% | -2.61% | -20.76% |
Profit Margin | -2.12% | 3.38% | 3.45% | 1.91% | -3.17% | -20.85% |
FCF Margin | 7.18% | 2.28% | 0.43% | -1.48% | 6.59% | -21.43% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | 23.75 | 21.70 | 55.95 | - | - |
Forward PE | - | 34.24 | 34.24 | 34.24 | 34.24 | 34.24 |
P/FCF Ratio | 10.15 | 35.17 | 174.54 | - | 16.35 | - |
PS Ratio | 0.73 | 0.80 | 0.75 | 1.07 | 1.08 | 1.50 |